NO156721B - Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-etyl-6 fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-1,8-naftyridin-3-karboksylsyre. sesquihydrat. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-etyl-6 fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-1,8-naftyridin-3-karboksylsyre. sesquihydrat.Info
- Publication number
- NO156721B NO156721B NO820430A NO820430A NO156721B NO 156721 B NO156721 B NO 156721B NO 820430 A NO820430 A NO 820430A NO 820430 A NO820430 A NO 820430A NO 156721 B NO156721 B NO 156721B
- Authority
- NO
- Norway
- Prior art keywords
- navythyridine
- sesquihydrate
- fluor
- piperazinyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56020749A JPS57134482A (en) | 1981-02-13 | 1981-02-13 | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO820430L NO820430L (no) | 1982-08-16 |
| NO156721B true NO156721B (no) | 1987-08-03 |
| NO156721C NO156721C (no) | 1987-11-11 |
Family
ID=12035831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO820430A NO156721C (no) | 1981-02-13 | 1982-02-12 | Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-etyl-6 fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-1,8-naftyridin-3-karboksylsyre. sesquihydrat. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4442101A (no) |
| EP (1) | EP0058614B1 (no) |
| JP (1) | JPS57134482A (no) |
| KR (1) | KR870000322B1 (no) |
| AU (1) | AU547082B2 (no) |
| CA (1) | CA1216292A (no) |
| CS (1) | CS254958B2 (no) |
| DD (1) | DD202573A5 (no) |
| DE (1) | DE3266261D1 (no) |
| DK (1) | DK160046C (no) |
| ES (1) | ES509538A0 (no) |
| FI (1) | FI71144C (no) |
| HU (1) | HU186473B (no) |
| MX (1) | MX158194A (no) |
| NO (1) | NO156721C (no) |
| PH (1) | PH18177A (no) |
| PL (1) | PL137259B1 (no) |
| YU (1) | YU43785B (no) |
| ZA (1) | ZA82740B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2758259A (en) * | 1953-06-23 | 1956-08-07 | Mallory & Co Inc P R | Electrolytic capacitor device |
| US2856570A (en) * | 1954-06-02 | 1958-10-14 | Mallory & Co Inc P R | Electrolytic capacitor |
| JPS57134482A (en) * | 1981-02-13 | 1982-08-19 | Dainippon Pharmaceut Co Ltd | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
| DE3308908A1 (de) * | 1983-03-12 | 1984-09-13 | Bayer Ag, 5090 Leverkusen | Bakterizide mittel |
| US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
| HUT40429A (en) * | 1985-04-29 | 1986-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of salts of derivatives of kynolin carbonic acid |
| US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
| US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
| JP3449658B2 (ja) * | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| GB9820405D0 (en) | 1998-09-18 | 1998-11-11 | Smithkline Beecham Plc | Process |
| GB9920919D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel compound |
| GB9920917D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel process |
| KR100517638B1 (ko) | 2002-04-08 | 2005-09-28 | 주식회사 엘지생명과학 | 게미플록사신 산염의 새로운 제조방법 |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US8629178B2 (en) * | 2009-11-03 | 2014-01-14 | Li Liu | Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof |
| US20160046603A1 (en) * | 2013-03-08 | 2016-02-18 | Melinta Therapeutics, Inc. | Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate |
| KR102214067B1 (ko) | 2014-02-27 | 2021-02-09 | 엘지전자 주식회사 | 산 질화물 형광체, 그 제조 방법 및 이를 이용한 발광 소자 패키지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149104A (en) * | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
| US3590036A (en) * | 1968-11-18 | 1971-06-29 | George Y Lesher | Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof |
| CA947301A (en) * | 1970-01-28 | 1974-05-14 | Sumitomo Chemical Company | Process for the preparation of compound having antibacterial action |
| US4017622A (en) * | 1972-12-18 | 1977-04-12 | Dainippon Pharmaceutical Co., Ltd. | Piperazine derivatives |
| JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
| JPS5845426B2 (ja) * | 1978-09-29 | 1983-10-08 | 杏林製薬株式会社 | 置換キノリンカルボン酸誘導体 |
| JPS57134482A (en) * | 1981-02-13 | 1982-08-19 | Dainippon Pharmaceut Co Ltd | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
-
1981
- 1981-02-13 JP JP56020749A patent/JPS57134482A/ja active Granted
-
1982
- 1982-02-03 AU AU80173/82A patent/AU547082B2/en not_active Expired
- 1982-02-04 US US06/345,916 patent/US4442101A/en not_active Expired - Lifetime
- 1982-02-05 ZA ZA82740A patent/ZA82740B/xx unknown
- 1982-02-08 YU YU265/82A patent/YU43785B/xx unknown
- 1982-02-11 DE DE8282400247T patent/DE3266261D1/de not_active Expired
- 1982-02-11 DD DD82237353A patent/DD202573A5/de not_active IP Right Cessation
- 1982-02-11 EP EP82400247A patent/EP0058614B1/en not_active Expired
- 1982-02-12 PH PH26864A patent/PH18177A/en unknown
- 1982-02-12 DK DK063482A patent/DK160046C/da not_active IP Right Cessation
- 1982-02-12 NO NO820430A patent/NO156721C/no not_active IP Right Cessation
- 1982-02-12 PL PL1982235049A patent/PL137259B1/pl unknown
- 1982-02-12 ES ES509538A patent/ES509538A0/es active Granted
- 1982-02-12 MX MX191383A patent/MX158194A/es unknown
- 1982-02-12 CA CA000396209A patent/CA1216292A/en not_active Expired
- 1982-02-12 HU HU82439A patent/HU186473B/hu unknown
- 1982-02-12 CS CS82998A patent/CS254958B2/cs unknown
- 1982-02-12 FI FI820466A patent/FI71144C/fi not_active IP Right Cessation
- 1982-02-13 KR KR8200633A patent/KR870000322B1/ko active
Also Published As
| Publication number | Publication date |
|---|---|
| FI71144B (fi) | 1986-08-14 |
| FI71144C (fi) | 1986-11-24 |
| EP0058614B1 (en) | 1985-09-18 |
| HU186473B (en) | 1985-08-28 |
| KR870000322B1 (ko) | 1987-02-27 |
| JPS57134482A (en) | 1982-08-19 |
| DK63482A (da) | 1982-08-14 |
| NO820430L (no) | 1982-08-16 |
| YU26582A (en) | 1986-04-30 |
| YU43785B (en) | 1989-12-31 |
| DK160046C (da) | 1991-06-10 |
| CS99882A2 (en) | 1987-07-16 |
| PH18177A (en) | 1985-04-12 |
| PL137259B1 (en) | 1986-05-31 |
| ZA82740B (en) | 1982-12-29 |
| US4442101A (en) | 1984-04-10 |
| AU547082B2 (en) | 1985-10-03 |
| FI820466L (fi) | 1982-08-14 |
| CS254958B2 (en) | 1988-02-15 |
| AU8017382A (en) | 1982-08-19 |
| DK160046B (da) | 1991-01-21 |
| PL235049A1 (no) | 1982-09-27 |
| JPH0243753B2 (no) | 1990-10-01 |
| ES8307793A1 (es) | 1983-08-01 |
| MX158194A (es) | 1989-01-16 |
| EP0058614A1 (en) | 1982-08-25 |
| ES509538A0 (es) | 1983-08-01 |
| DE3266261D1 (en) | 1985-10-24 |
| DD202573A5 (de) | 1983-09-21 |
| NO156721C (no) | 1987-11-11 |
| KR830009096A (ko) | 1983-12-17 |
| CA1216292A (en) | 1987-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO156721B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-etyl-6 fluor-1,4-dihydro-4-okso-7-(1-piperazinyl)-1,8-naftyridin-3-karboksylsyre. sesquihydrat. | |
| NO159446C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO832431L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| NO153927C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-substituerte 4-amino-3-kinolinsyrederivater. | |
| NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
| NO852885L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater. | |
| NO166320C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO158060C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser. | |
| NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO158534C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater. | |
| NO167204C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser. | |
| NO161066C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater. | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO168037C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. | |
| NO164020C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| NO811346L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater. | |
| NO158673C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. | |
| NO171016C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater | |
| NO159532C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 1-(4-kinolyl)-2-(4-piperidyl)-etanol eller1-(4-kinolyl)-3-(4-piperidyl)-propanol. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |
Free format text: EXPIRED IN FEBRUARY 2002 |